Stability of ceftazidime sodium and teicoplanin sodium in a peritoneal dialysis solution

American Journal of Health-System Pharmacy

Volumn 53, Issue 22, 1996, Pages 2731-2734

  Manduru, Madhavi ^a   Fariello, Andrew ^b   White, Roger L ^c   Fox, Janet L ^d   Bosso, John A ^a,c  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b JOHNS HOPKINS ALL CHILDREN S HOSPITAL   (United States)

^c Department of Pharmacy Practice   (United States)

^d GLAXOSMITHKLINE   (United States)

Author keywords

Additives; Antibiotics; Ceftazidime sodium; Cephalosporins; Dialysis; Incompatibilities; Injections; Peritoneal dialysis solutions; Stability; Storage; Teicoplanin sodium; Temperature

Indexed keywords

CEFTAZIDIME; DIANEAL; PERITONEAL DIALYSIS FLUID; TEICOPLANIN;

ARTICLE; CONTROLLED STUDY; DRUG STABILITY; DRUG STORAGE; PRIORITY JOURNAL; TEMPERATURE DEPENDENCE;

EID: 0029955822     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/53.22.2731     Document Type: Article

References (12)

1. Johnson AP, Uttley AH, Woodford N et al. Resistance to vancomycin and teicoplanin: an emerging clinical problem. Clin Microbiol Rev. 1990; 3:280-91.
2. Stille W, Sietzen W, Dieterich H-A et al. Clinical efficacy and safety of teicoplanin. J Antimicrob Chemother. 1988; 21(suppl A):69-79.
3. Babul N, Pasko M. Teicoplanin: a new glycopeptide antibiotic complex. Drug Intell Clin Pharm. 1988; 22:218-26.
4. Sahai J, Healy DP, Shelton MJ et al. Comparison of vancomycin- and teicoplanin-induced histamine release and red-man syndrome. Antimicrob Agents Chemother. 1990; 34:765-9.
5. Bowley JA, Pickering SJ, Scantlebury P et al. Intraperitoneal teicoplanin in the treatment of peritonitis associated with continuous ambulatory peritoneal dialysis. J Antimicrob Chemother. 1988; 21(suppl A):133-9.
6. Beaman M, Solaro L, McGonigle RJS et al. Vancomycin and ceftazidime in the treatment of CAPD peritonitis. Nephron. 1989; 51:51-5.
7. Gray HH, Goulding S, Eykyn SJ. Intraperitoneal vancomycin and ceftazidime in the treatment of CAPD peritonitis. Clin Nephrol. 1985; 23:81-4.
8. Mawhinney WM, Adair CG, Gorman SP et al. Long-term stability of teicoplanin in dialysis fluid: implications for the home-treatment of CAPD peritonitis. Int J Pharm Pract. 1993; 1:90-3.
9. Mason NA, Johnson CE, O'Brien MA. Stability of ceftazidime and tobramycin sulfate in peritoneal dialysis solution. Am J Hosp Pharm. 1992; 49:1139-42.
10. Vaughan LM, Poon CY. Stability of ceftazidime and vancomycin alone and in combination in heparinized and nonheparinized peritoneal dialysis solution. Ann Pharmacother. 1994; 28:572-5.
11. Bosso JA, Taylor AJ, Fox JL et al. Compatibility of anakinra with ondansetron, ceftazidime, cefuroxime and ranitidine solutions under simulated Y-site conditions. J Infect Dis Pharmacother. 1995; 1:67-75.
12. McMullin CM, White LO, MacGowan AP et al. Assay of serum teicoplanin concentrations in clinical specimens: a comparison of isocratic high performance liquid chromatography with polarization fluoroimmunoassay and bioassay. J Antimicrob Chemother. 1994; 34:425-9.